低氧性呼吸衰竭的无创通气阈值是否存在?一项队列研究
该队列研究基于MIMIC-IV(2008-2019)和AmsterdamUMCdb(2003-2016)数据库,纳入接受FiO2≥0.4的无重复呼吸面罩、无创正压通气或高流量鼻导管吸氧的ICU患者,评估17项生理学阈值(包括动脉血氧分压与吸入氧浓度比、血氧饱和度与吸入氧浓度比、复合评分及随机试验标准)达到后3小时内接受有创通气的概率。共纳入4726例患者(MIMIC 3365例,AmsterdamUMCdb 1361例),28%(1320例)接受有创通气。在MIMIC中,达到阈值后3小时内接受有创通气的最高概率为20%(使用血管加压药时满足预设的神经或呼吸标准)和19%(动脉血氧分压与吸入氧浓度比<80 mm Hg);在AmsterdamUMCdb中,最高概率为34%(启动血管加压药后)和25%(血氧饱和度与吸入氧浓度比<90)。达到随机试验阈值后的概率分别为9%(MIMIC)和13%(AmsterdamUMCdb)。在MIMIC中,与白人相比,黑人(OR,0.75;95% CrI,0.57-0.96)或亚裔(OR,0.6;95% CrI,0.35-0.95)在达到阈值后接受有创通气的概率较低。
要点
- 在低氧性呼吸衰竭患者中,达到生理学阈值后3小时内接受有创通气的概率低,最高为20%(MIMIC,使用血管加压药时满足预设的神经或呼吸标准)和34%(AmsterdamUMCdb,启动血管加压药后)。
- 达到随机试验阈值后3小时内接受有创通气的概率分别为9%(MIMIC)和13%(AmsterdamUMCdb)。
- 在MIMIC中,黑人(OR,0.75;95% CrI,0.57-0.96)或亚裔(OR,0.6;95% CrI,0.35-0.95)与白人相比,达到阈值后接受有创通气的概率较低。
- 动脉血氧分压与吸入氧浓度比<80 mm Hg后3小时内接受有创通气的概率为19%(MIMIC);血氧饱和度与吸入氧浓度比<90后为25%(AmsterdamUMCdb)。
适用人群与场景
- 接受FiO2≥0.4的无重复呼吸面罩、无创正压通气或高流量鼻导管吸氧的ICU患者(MIMIC-IV数据库2008-2019年,AmsterdamUMCdb数据库2003-2016年)。
诊断标准与关键阈值
- 评估了17项阈值,包括动脉血氧分压与吸入氧浓度比、血氧饱和度与吸入氧浓度比、复合评分及随机试验标准。
- 具体阈值包括:动脉血氧分压与吸入氧浓度比<80 mm Hg;血氧饱和度与吸入氧浓度比<90;使用血管加压药时满足预设的神经或呼吸标准;启动血管加压药。
研究设计与关键结果
- 研究类型:队列研究;样本量:4726例(MIMIC 3365例,AmsterdamUMCdb 1361例);28%(1320例)接受有创通气。
- 在MIMIC中,达到阈值后3小时内接受有创通气的最高概率为20%(使用血管加压药时满足预设的神经或呼吸标准)和19%(动脉血氧分压与吸入氧浓度比<80 mm Hg)。
- 在AmsterdamUMCdb中,最高概率为34%(启动血管加压药后)和25%(血氧饱和度与吸入氧浓度比<90)。
- 达到随机试验阈值后3小时内接受有创通气的概率为9%(MIMIC)和13%(AmsterdamUMCdb)。
- 在MIMIC中,与白人相比,黑人(OR,0.75;95% CrI,0.57-0.96)或亚裔(OR,0.6;95% CrI,0.35-0.95)达到阈值后接受有创通气的概率较低。
证据类型、等级与局限
- 证据类型:队列研究(基于MIMIC-IV和AmsterdamUMCdb数据库)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论:达到生理学阈值后3小时内接受有创通气的概率低,且与患者种族/族裔相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Invasive ventilation is a significant event for patients with respiratory failure. Physiologic thresholds standardize the use of invasive ventilation in clinical trials, but it is unknown whether thresholds prompt invasive ventilation in clinical practice. Objectives: To measure, in patients with hypoxemic respiratory failure, the probability of invasive ventilation within 3 hours after meeting physiologic thresholds. Methods: We studied patients admitted to intensive care receiving FiO2 of 0.4 or more via nonrebreather mask, noninvasive positive pressure ventilation, or high-flow nasal cannula, using data from the Medical Information Mart for Intensive Care (MIMIC)-IV database (2008-2019) and the Amsterdam University Medical Centers Database (AmsterdamUMCdb) (2003-2016). We evaluated 17 thresholds, including the ratio of arterial to inspired oxygen, the ratio of saturation to inspired oxygen ratio, composite scores, and criteria from randomized trials. We report the probability of invasive ventilation within 3 hours of meeting each threshold and its association with covariates using odds ratios (ORs) and 95% credible intervals (CrIs). Measurements and Main Results: We studied 4,726 patients (3,365 from MIMIC, 1,361 from AmsterdamUMCdb). Invasive ventilation occurred in 28% (1,320). In MIMIC, the highest probability of invasive ventilation within 3 hours of meeting a threshold was 20%, after meeting prespecified neurologic or respiratory criteria while on vasopressors, and 19%, after a ratio of arterial to inspired oxygen of <80 mm Hg. In AmsterdamUMCdb, the highest probability was 34%, after vasopressor initiation, and 25%, after a ratio of saturation to inspired oxygen of <90. The probability after meeting the threshold from randomized trials was 9% (MIMIC) and 13% (AmsterdamUMCdb). In MIMIC, a race/ethnicity of Black (OR, 0.75; 95% CrI, 0.57-0.96) or Asian (OR, 0.6; 95% CrI, 0.35-0.95) compared with White was associated with decreased probability of invasive ventilation after meeting a threshold. Conclusions: The probability of invasive ventilation within 3 hours of meeting physiologic thresholds was low and associated with patient race/ethnicity.
参考来源
- Yarnell CJ, Johnson A, Dam T, et al. Do Thresholds for Invasive Ventilation in Hypoxemic Respiratory Failure Exist? A Cohort Study. Am J Respir Crit Care Med. 2023. PMID: 36150166. doi:10.1164/rccm.202206-1092OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。